6 recruiting, 2 enrolling by invitation, 2 not yet recruiting, 1 completed. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
Follow Gene Solutions: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Validation of the SPOT-MAS Lung Test Using Circulating Tumor DNA for the Detection of Lung Cancer Lung Diseases, Lung Cancer Screening | Not yet recruiting | Gene Solutions | 1184 | 2025-08-18 | 2025-08-17 | |
| Assessing Systemic Treatment and ctDNA Monitoring Efficacy in Metastatic Cancer Patients Using K4Care Testing. Metastatic Cancers | Recruiting | Gene Solutions | 200 | 2025-04-09 | 2025-07-16 | |
| Predictive Value of PREMM5, MMRpredict, and Universal Tumor Screening for Lynch Syndrome in Vietnam Lynch Syndrome, Colorectal Cancer (CRC) | Not yet recruiting | University of Medicine and Pharmacy at Ho Chi Minh City | 572 | 2025-03-17 | 2025-03-07 | |
| Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals Liquid Biopsy (SPOT-MAS Assay), Exosome-Based Liquid Biopsy Assay, Low-Dose CT Thorax (LDCT) - Lung Cancer, Lung Neoplasms | Not applicable | Recruiting | National University Hospital, Singapore | 140 | 2024-11-01 | 2026-01-22 |
| Clinical Validation of an MCED Test in Symptomatic Populations (K-ACCELERATE) Cancer Colon, Cancer, Liver | Enrolling by invitation | Gene Solutions | 1000 | 2024-07-30 | 2025-07-16 | |
| ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer Rectal Cancer, Rectal Cancer Stage II | Recruiting | Gene Solutions | 100 | 2024-05-21 | 2024-09-19 | |
| Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women by Non-invasive Prenatal Test Pregnant With Complication, Preeclampsia | Enrolling by invitation | Gene Solutions | 1105 | 2024-05-10 | 2025-07-16 | |
| Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer. Non Small Cell Lung Cancer, Breast Cancer | Recruiting | Gene Solutions | 50 | 2024-03-22 | 2026-01-16 | |
| Analysis of Circulating Tumor DNA Dynamics to Predict and Monitor Response to TKI in Patients With Advanced NSCLC. Non Small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Recruiting | Gene Solutions | 50 | 2023-12-04 | 2025-07-16 | |
| Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment Breast Cancer Female, Stage II Breast Cancer | Recruiting | Gene Solutions | 125 | 2023-09-16 | 2025-09-23 | |
| Early Detection of Five Common Cancers Using the ctDNA Analysing Test Cancer, Lung, Cancer, Breast | Completed | Gene Solutions | 9057 | 2022-04-10 | 2025-02-18 |
Breast Neoplasms (4) · Colorectal Neoplasms (3) · Lung Neoplasms (3) · Stomach Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (2) · Liver Neoplasms (2) · Carcinoma, Hepatocellular (1) · Colonic Neoplasms (1) · Colorectal Neoplasms, Hereditary Nonpolyposis (1) · Diabetes, Gestational (1) · Lung Diseases (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Pre-Eclampsia (1) · Pregnancy Complications (1)
Liquid Biopsy (1)
Vietnam (10) · Indonesia (1) · Singapore (1)
Sinh D Nguyen, PhD (2) · Doan TN Nguyen, MD (1) · Samuel J Haryono, MD (1) · Sinh D Nguyen (1) · Sinh D Nguyen, PHD (1) · Trung Q Lam, MD (1)